Global Cell Therapy Human Raw Materials Market Size & Outlook
Global cell therapy human raw materials market, 2021-2033 (US$M)
Related Markets
Global cell therapy human raw materials market highlights
- The global cell therapy human raw materials market generated a revenue of USD 4,373.3 million in 2025 and is expected to reach USD 16,791.5 million by 2033.
- The market is expected to grow at a CAGR (2026 - 2033) of 18.4% by 2033.
- In terms of segment, cell culture supplements accounted for a revenue of USD 1,429.8 million in 2025.
- Cell Culture Media is the most lucrative product segment registering the fastest growth during the forecast period.
- In terms of region, North America was the largest revenue generating market in 2025.
- Country-wise, UK is expected to register the highest CAGR from 2026 to 2033.
Global data book summary
| Market revenue in 2025 | USD 4,373.3 million |
| Market revenue in 2033 | USD 16,791.5 million |
| Growth rate | 18.4% (CAGR from 2026 to 2033) |
| Largest segment | Cell culture supplements |
| Fastest growing segment | Cell Culture Media |
| Historical data covered | 2021 - 2024 |
| Base year for estimation | 2025 |
| Forecast period covered | 2026 - 2033 |
| Quantitative units | Revenue in USD million |
| Market segmentation | Cell Culture Media, Cell Culture Sera, Reagents & Buffers, Other Raw Materials, Cell Culture Supplements |
Other key industry trends
- In terms of revenue, the North America accounted for 46.0% of the global cell therapy human raw materials market in 2025.
- By country, the U.S. is projected to lead the global market in terms of revenue in 2033.
- By country, UK is the fastest growing regional market and is projected to reach USD 919.4 million by 2033.
No credit card required*
Horizon in a snapshot
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
Cell Therapy Human Raw Materials Market Scope
Cell Therapy Human Raw Materials Market Companies
| Name | Profile | # Employees | HQ | Website |
|---|---|---|---|---|
| Geminibio | View profile | 1-10 | San Diego, California, United States, North America | https://www.gembioinc.com |
| CGT Global | View profile | 51-100 | Folsom, California, United States, North America | https://cgt.global |
| BioIVT | View profile | 251-500 | Westbury, New York, United States, North America | https://bioivt.com |
| Grifols, S.A. | View profile | - | - | - |
| Charles River Laboratories | View profile | - | - | - |
| AllCells | View profile | 51-100 | Alameda, California, United States, North America | https://www.allcells.com |
| STEMCELL Technologies | View profile | 501-1000 | Vancouver, British Columbia, Canada, North America | https://www.stemcell.com |
| Akron Biotechnology | View profile | 11-50 | Boca Raton, Florida, United States, North America | https://www.akronbiotech.com |
| RoosterBio | View profile | 1-10 | Frederick, Maryland, United States, North America | http://roosterbio.com |
| ACROBiosystems | View profile | 251-500 | Newark, Delaware, United States, North America | https://www.acrobiosystems.com/ |
| Actylis | View profile | 501-1000 | Port Washington, New York, United States, North America | https://actylis.com |
| PromoCell GmbH | View profile | 51-100 | Heidelberg, Baden-Wurttemberg, Germany, Europe | http://www.promocell.com/ |
| Danaher Corp | View profile | 63000 | 2200 Pennsylvania Avenue, N.W., Suite 800W, Washington, DC, United States, 20037-1701 | https://www.danaher.com |
| Thermo Fisher Scientific Inc | View profile | 122000 | 168 Third Avenue, Waltham, MA, United States, 02451 | https://www.thermofisher.com |
| Merck KGaA | View profile | 62345 | Frankfurter Strasse 250, Darmstadt, HE, Germany, 64293 | https://www.emdgroup.com |
Global cell therapy human raw materials market outlook
The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to cell therapy human raw materials market will help companies and investors design strategic landscapes.
Cell culture supplements was the largest segment with a revenue share of 32.69% in 2025. Horizon Databook has segmented the Global cell therapy human raw materials market based on cell culture media, cell culture sera, reagents & buffers, other raw materials, cell culture supplements covering the revenue growth of each sub-segment from 2021 to 2033.
- Global Cell Therapy Human Raw Materials Product Outlook (Revenue, USD Million, 2021-2033)
- Cell Culture Media
- Cell Culture Sera
- Reagents & Buffers
- Other Raw Materials
- Cell Culture Supplements
- Proteins
- Growth Factors
- Nucleotides
- Other Supplements
- Global Cell Therapy Human Raw Materials End Use Outlook (Revenue, USD Million, 2021-2033)
- Biopharmaceutical & Pharmaceutical Companies
- CROs & CMOs
- Academic & Research Institutions
Reasons to subscribe to Global cell therapy human raw materials market databook:
-
Access to comprehensive data: Horizon Databook provides over 1 million market statistics and 20,000+ reports, offering extensive coverage across various industries and regions.
-
Informed decision making: Subscribers gain insights into market trends, customer preferences, and competitor strategies, empowering informed business decisions.
-
Cost-Effective solution: It's recognized as the world's most cost-effective market research database, offering high ROI through its vast repository of data and reports.
-
Customizable reports: Tailored reports and analytics allow companies to drill down into specific markets, demographics, or product segments, adapting to unique business needs.
-
Strategic advantage: By staying updated with the latest market intelligence, companies can stay ahead of competitors, anticipate industry shifts, and capitalize on emerging opportunities.
Target buyers of Global cell therapy human raw materials market databook
-
Our clientele includes a mix of cell therapy human raw materials market companies, investment firms, advisory firms & academic institutions.
-
30% of our revenue is generated working with investment firms and helping them identify viable opportunity areas.
-
Approximately 65% of our revenue is generated working with competitive intelligence & market intelligence teams of market participants (manufacturers, service providers, etc.).
-
The rest of the revenue is generated working with academic and research not-for-profit institutes. We do our bit of pro-bono by working with these institutions at subsidized rates.
Horizon Databook provides a detailed overview of global-level data and insights on the Global cell therapy human raw materials market , including forecasts for subscribers. This global databook contains high-level insights into Global cell therapy human raw materials market from 2021 to 2033, including revenue numbers, major trends, and company profiles.
Partial client list
Global cell therapy human raw materials market size, by regions, 2021-2033 (US$M)
Top 10 countries: Cell therapy human raw materials market size, 2025 (US$M)
Global cell therapy human raw materials market share, by product, 2025 & 2033 (%, US$M)
Cell therapy human raw materials market: Opportunity assessment by country
Global cell therapy human raw materials market, by region, 2025 (US$M)
Related statistics
Sign up - it's easy, and free!
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
